Pharmaceuticals

Pfizer Inc. (PFE) recently announced its decision to voluntarily withdraw its pulmonary arterial hypertension (PAH) drug, Thelin, from the market. The company decided to withdraw Thelin based on a review of safety information on the drug from clinical studies and post-marketing reports....

Roche Holdings Ltd. (RHHBY) recently reported positive mid-stage data on Herceptin given in combination with pertuzumab and docetaxel in women with early-stage, HER2-positive breast cancer. In a phase II trial (NEOSPHERE), the two drugs – Herceptin and pertuzumab – along with docetaxel were...

Roche Holdings Ltd. (RHHBY) recently reported positive mid-stage data on Herceptin given in combination with pertuzumab and docetaxel in women with early-stage, HER2-positive breast cancer. In a phase II trial (NEOSPHERE), the two drugs – Herceptin and pertuzumab – along with docetaxel were...

Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...

The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent first-quarter 2011 dividend on the company's common stock, payable March 1, 2011, to shareholders of record at the close of business on February 4, 2011. Pfizer increased the dividend by approximately 11 percent, to 20...

Pfizer Inc. (NYSE: PFE) announced today that the Company's Board of Directors has elected George A. Lorch, 68, who has served as an independent director since 2000, as non-executive Chairman of the Board, effective immediately.

Lannett Company, Inc. (NYSE: LCI) today announced that it intends, subject to market and other conditions, to offer its common stock in a registered public offering pursuant to its existing shelf registration statement under the Securities Act of 1933. Lannett also intends to grant the...

Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...

Shares of Elan Corporation (NYSE: ELN) are higher on the session by 2.43%, trading at $5.89. Overall put volume is now running at 4.12x the daily average, with 63% of all puts traded being purchases on the offer. 1,503 contracts have traded on the session so far. Elan Corporation, plc is a...

Shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) are lower on the session by 1.37%, currently trading at $18.69. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying puts on the name today....

Biodel Inc.'s (BIOD) fourth quarter fiscal 2010 (ended September 30) loss of 31 cents per share was narrower than the loss of 37 cents indicated by the Zacks Consensus Estimate. The biopharmaceutical company reported a loss of 44 cents per share in the year-ago quarter. The narrower loss was...

Biodel Inc.'s (BIOD) fourth quarter fiscal 2010 (ended September 30) loss of 31 cents per share was narrower than the loss of 37 cents indicated by the Zacks Consensus Estimate. The biopharmaceutical company reported a loss of 44 cents per share in the year-ago quarter. The narrower loss was...

Lannett Company, Inc. (AMEX: LCI) is plunging today, down more than 16% on no news. The company's PDUFA date is approximately December 26. Aa PDUFA is a Supplemental New Drug Applications (NDAs) or Biologic License Application (BLAs) are filed to obtain FDA marketing clearance for a new use,...